{
  "metadata": {
    "generated_at": "2025-12-28T09:25:38.365640",
    "deliverable": "D3",
    "total_trials_found": 39
  },
  "trials": [
    {
      "nct_id": "NCT07022535",
      "title": "Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT07022535"
    },
    {
      "nct_id": "NCT06232122",
      "title": "Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT06232122"
    },
    {
      "nct_id": "NCT04590326",
      "title": "A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab",
      "url": "https://clinicaltrials.gov/study/NCT04590326"
    },
    {
      "nct_id": "NCT07153705",
      "title": "OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT07153705"
    },
    {
      "nct_id": "NCT00083928",
      "title": "Efficacy of \u00c56 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels",
      "url": "https://clinicaltrials.gov/study/NCT00083928"
    },
    {
      "nct_id": "NCT05801263",
      "title": "ctDNA Methylation for Epithelial Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT05801263"
    },
    {
      "nct_id": "NCT00442598",
      "title": "Safety and Efficacy Study of Glufosfamide in Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT00442598"
    },
    {
      "nct_id": "NCT02289950",
      "title": "A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Participants With Low CA125 Platinum-sensitive Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT02289950"
    },
    {
      "nct_id": "NCT07295132",
      "title": "RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)",
      "url": "https://clinicaltrials.gov/study/NCT07295132"
    },
    {
      "nct_id": "NCT00926107",
      "title": "Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse",
      "url": "https://clinicaltrials.gov/study/NCT00926107"
    },
    {
      "nct_id": "NCT02109367",
      "title": "Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass",
      "url": "https://clinicaltrials.gov/study/NCT02109367"
    },
    {
      "nct_id": "NCT01616303",
      "title": "A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT01616303"
    },
    {
      "nct_id": "NCT06129968",
      "title": "Transforming Ovarian Cancer Diagnostic Pathways",
      "url": "https://clinicaltrials.gov/study/NCT06129968"
    },
    {
      "nct_id": "NCT00050375",
      "title": "Clinical Trial for Ovarian Cancer (OvaRex\u00ae)",
      "url": "https://clinicaltrials.gov/study/NCT00050375"
    },
    {
      "nct_id": "NCT00086567",
      "title": "Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers",
      "url": "https://clinicaltrials.gov/study/NCT00086567"
    },
    {
      "nct_id": "NCT03193671",
      "title": "Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis",
      "url": "https://clinicaltrials.gov/study/NCT03193671"
    },
    {
      "nct_id": "NCT02432690",
      "title": "A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation",
      "url": "https://clinicaltrials.gov/study/NCT02432690"
    },
    {
      "nct_id": "NCT02326064",
      "title": "Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4",
      "url": "https://clinicaltrials.gov/study/NCT02326064"
    },
    {
      "nct_id": "NCT02296307",
      "title": "DOvEE - Diagnosing Ovarian & Endometrial Cancer Early",
      "url": "https://clinicaltrials.gov/study/NCT02296307"
    },
    {
      "nct_id": "NCT06558019",
      "title": "Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence",
      "url": "https://clinicaltrials.gov/study/NCT06558019"
    },
    {
      "nct_id": "NCT03564340",
      "title": "Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers",
      "url": "https://clinicaltrials.gov/study/NCT03564340"
    },
    {
      "nct_id": "NCT04938583",
      "title": "Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT04938583"
    },
    {
      "nct_id": "NCT01111903",
      "title": "A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse",
      "url": "https://clinicaltrials.gov/study/NCT01111903"
    },
    {
      "nct_id": "NCT05801276",
      "title": "ctDNA Methylation for Detecting Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT05801276"
    },
    {
      "nct_id": "NCT06182917",
      "title": "Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients",
      "url": "https://clinicaltrials.gov/study/NCT06182917"
    },
    {
      "nct_id": "NCT05080556",
      "title": "Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT05080556"
    },
    {
      "nct_id": "NCT00080639",
      "title": "CA-125 in Screening Patients at High Risk for Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT00080639"
    },
    {
      "nct_id": "NCT04826029",
      "title": "Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer",
      "url": "https://clinicaltrials.gov/study/NCT04826029"
    },
    {
      "nct_id": "NCT03004391",
      "title": "Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125",
      "url": "https://clinicaltrials.gov/study/NCT03004391"
    },
    {
      "nct_id": "NCT01133756",
      "title": "E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125",
      "url": "https://clinicaltrials.gov/study/NCT01133756"
    },
    {
      "nct_id": "NCT00539162",
      "title": "Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women",
      "url": "https://clinicaltrials.gov/study/NCT00539162"
    },
    {
      "nct_id": "NCT00987649",
      "title": "Ovarian Cancer Risk Estimation in Patients With Pelvic Mass",
      "url": "https://clinicaltrials.gov/study/NCT00987649"
    },
    {
      "nct_id": "NCT04811703",
      "title": "Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT04811703"
    },
    {
      "nct_id": "NCT02595281",
      "title": "HE4 as a Relapse Biomarker in Ovarian Cancers",
      "url": "https://clinicaltrials.gov/study/NCT02595281"
    },
    {
      "nct_id": "NCT00043472",
      "title": "Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk",
      "url": "https://clinicaltrials.gov/study/NCT00043472"
    },
    {
      "nct_id": "NCT02247323",
      "title": "Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125",
      "url": "https://clinicaltrials.gov/study/NCT02247323"
    },
    {
      "nct_id": "NCT00587093",
      "title": "A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT00587093"
    },
    {
      "nct_id": "NCT00058032",
      "title": "CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women",
      "url": "https://clinicaltrials.gov/study/NCT00058032"
    },
    {
      "nct_id": "NCT05311579",
      "title": "Niraparib Plus Anlotinib for Recurrent Ovarian Cancer",
      "url": "https://clinicaltrials.gov/study/NCT05311579"
    }
  ]
}